➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
AstraZeneca
Medtronic
Colorcon
Express Scripts

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

LUVOX Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Luvox patents expire, and when can generic versions of Luvox launch?

Luvox is a drug marketed by Ani Pharms, Solvay, and Jazz Pharms. and is included in three NDAs. There is one patent protecting this drug and two Paragraph IV challenges.

The generic ingredient in LUVOX is fluvoxamine maleate. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the fluvoxamine maleate profile page.

US ANDA Litigation and Generic Entry Outlook for Luvox

A generic version of LUVOX was approved as fluvoxamine maleate by UPSHER SMITH LABS on November 29th, 2000.

  Start Trial

US Patents and Regulatory Information for LUVOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms LUVOX fluvoxamine maleate TABLET;ORAL 021519-001 Dec 20, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-004 Dec 5, 1994 DISCN Yes No   Start Trial   Start Trial   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-001 Dec 5, 1994 DISCN Yes No   Start Trial   Start Trial   Start Trial
Jazz Pharms LUVOX CR fluvoxamine maleate CAPSULE, EXTENDED RELEASE;ORAL 022033-001 Feb 28, 2008 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LUVOX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-001 Dec 5, 1994   Start Trial   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-003 Dec 5, 1994   Start Trial   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-002 Dec 5, 1994   Start Trial   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-004 Dec 5, 1994   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Mallinckrodt
Colorcon
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.